Ashkan Shoamanesh: Thrilled to Be Leading The Global INTERCEPT Trial
Ashkan Shoamanesh, Associate Professor of Medicine (Neurology), Marta and Owen Boris Chair in Stroke Research and Care at McMaster University, reposted from Hamilton Health Sciences on LinkedIn:
”Thrilled to be leading the global INTERCEPT trial alongside Alexander Benz and PJ Devereaux.
This trial addresses a major unmet need in patients with stroke and atrial fibrillation who continue to face a cumulative 5-year risk of recurrent stroke of 20–25% despite best medical therapy, including anticoagulation.
The Vine carotid filter system from Javelin Medical is a simple yet sophisticated device designed to prevent the most disabling and life-threatening recurrent strokes in these patients.
The device is implanted percutaneously through a fine needle under ultrasound guidance and does not require anaesthesia.
We are now expanding the trial to ~200 sites across 20 countries and have been thrilled with the outstanding early performance at Hamilton Health Sciences under the leadership of Aristeidis Katsanos, Brian van Adel, and Bill Wang, with Hamilton Health Sciences being the first hospital to ever perform this procedure outside of Europe.”
Quoting Hamilton Health Sciences‘s post:
”Filters keep coffee fresh, water clean, and cars running smoothly.
Now, a team of Hamilton Health Sciences doctors and researchers are using that same concept to prevent strokes, by placing tiny filters in patients’ carotid arteries at each side of the neck to trap blood clots so they can’t reach the brain.
We’re the first hospital site in North America and most of the world to perform this innovative new procedure to investigate whether these tiny filters, called Vine carotid filters, can lower the number of strokes caused by large vessel blockages inside the brain.
Read more about this global, Phase 3 clinical trial is taking place through a partnership with a medical device company and our Hamilton General Hospital’s stroke and neuro-intervention teams.”
Stay updated with Hemostasis Today.
-
Jul 2, 2026, 23:11Michael Makris: Join The Cancer Associated Thrombosis Workshop at ISTH 2026
-
Jul 2, 2026, 21:54Rob Maloney: Rare Disease Requires Relational Care
-
Jul 2, 2026, 21:53Quintijn Bonnez: How ADAMTS13 Conformation May Predict Early Relapse and Guide Pre-Emptive Therapy
-
Jul 2, 2026, 21:52Emina Curic: Improving the Understanding of Factor V Leiden in Everyday Clinical Practice
-
Jul 2, 2026, 21:49Lee Peter Bee: The Plastic in Your Blood Is Sabotaging Your Stem Cells
-
Jul 2, 2026, 21:49Atef Ahmed: The Lethal Triad and Damage Control Philosophy
-
Jul 2, 2026, 20:48João L. Carapinha: How Does HYMPAVZI Simplify Hemophilia Management for Patients?
-
Jul 2, 2026, 20:15Celebrationg The 30 Years Anniversary as The Voice of Stroke in Australia – Stroke Foundation
-
Jul 2, 2026, 19:40Minoo Ahmadinejad: Improving the Recognition of Women and Girls With Hemophilia